J&J Making Offer For J-Beauty Firm Ci:z Amid Throes Of Consumer Biz Revival
This article is powered by The Rose Sheet
Executive Summary
Johnson & Johnson intends to buy out Japan-based Ci:z Holdings for north of $2bn, which would give it full ownership of the firm’s dermocosmetic brand portfolio, including Dr.Ci:Labo, a standout performer for J&J’s beauty and larger consumer business in 2018.
You may also be interested in...
J&J's Baby, Beauty Sectors Boost Consumer Health Sales Rebound
Johnson’s baby product sales picked up in the third quarter after a rough start as its baby care division sales up 20% in the US to $120m. US consumer health sales grew 6.6% to $1.37bn, also helped by total worldwide beauty sales increasing 6.5% to $1.08bn.
J&J Relaunches Johnson’s Baby Care As Greener, Gentler, With Fewer Ingredients
The overhaul in line with “modern parents’ preferences” could be what’s needed to rouse the sleepy brand and spur Consumer business growth.
CVS Joins Retailers Cramming Shelves With K-Beauty Favorites
CVS teamed with Peach & Lily founder Alicia Yoon to curate an assortment of offerings from South Korean skin-care brands and Yoon’s own Peach Slices line, rolling out to 2,100 doors nationwide in April. With Target, Ulta and Sephora also building their K-beauty offerings, mainstream players may face growing competition for shelf space as millennials gravitate to the quirky and fun, and away from science-driven anti-aging.